What is the current Price Target for the RenovoRx Inc stock?

The average RenovoRx Inc target price is $3.25. This is 257.14% higher than the current stock price. The highest price target is 284.62%, the lowest is 229.67%. 2 Analysts have issued a price target RenovoRx Inc 2026 .

How high will the RenovoRx Inc stock rise?

No reliable answer can be given as to how high the RenovoRx Inc stock will rise. The performance of stocks, including the RenovoRx Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the RenovoRx Inc stock today?

The performance of RenovoRx Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the RenovoRx Inc stock fall?

The decline in RenovoRx Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

RenovoRx Inc Forecast, price target & analysts

$0.90

1.10% today

Nasdaq, Apr 04, 08:46 pm CET

ISIN

US75989R1077

Symbol

RNXT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

RenovoRx Inc Target price 2025 - Analyst rating & recommendation

RenovoRx Inc Classifications & Recommendation:

Buy

100%

RenovoRx Inc Price Target

Target Price	$3.25
Price	$0.91
Potential	257.14% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target RenovoRx Inc 2026 . The average RenovoRx Inc target price is $3.25. This is 257.14% register free of charge higher than the current stock price. The highest price target is $3.50 284.62% register free of charge , the lowest is $3.00 229.67% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend RenovoRx Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the RenovoRx Inc stock has an average upside potential 2026 of 257.14% register free of charge . Most analysts recommend the RenovoRx Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	0.04	2.05
		5,018.75%

2 Analysts have issued a sales forecast RenovoRx Inc 2025 . The average RenovoRx Inc sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$40.0k
2025	$2.0m 5,018.75% Unlock
2026	$5.9m 187.86% Unlock
2027	$19.9m 237.36% Unlock
2028	$36.4m 83.02% Unlock
2029	$84.3m 131.59% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		12.45

Based on analysts' sales estimates for 2025, the RenovoRx Inc stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	637.25
2025	12.45 98.05% Unlock
2026	4.32 65.26% Unlock
2027	1.28 70.36% Unlock
2028	0.70 45.36% Unlock
2029	0.30 56.82% Unlock

Current
2025	15.80 98.05% Unlock
2026	5.49 65.26% Unlock
2027	1.63 70.36% Unlock
2028	0.89 45.36% Unlock
2029	0.38 56.82% Unlock

RenovoRx Inc...

Current RenovoRx Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 27 2025
Ascendiant Capital	Locked ➜ Locked	Locked	Dec 10 2024
Ascendiant Capital	Locked ➜ Locked	Locked	Sep 12 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 27 2025
Locked Ascendiant Capital: Locked ➜ Locked	Dec 10 2024
Locked Ascendiant Capital: Locked ➜ Locked	Sep 12 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now